And what about the endothelium? On the predominance of cerebral superoxide formation for angiotensin II-induced systemic hypertension.
Ralf P
RP
Brandes
D000804:Angiotensin II / Q000633:toxicity*; D000818:Animals; D004730:Endothelium, Vascular / Q000378:metabolism*; D015316:Genetic Therapy; D006801:Humans; D006973:Hypertension / Q000139:chemically induced* / Q000503:physiopathology / Q000517:prevention & control; D051379:Mice; D008954:Models, Biological; D009474:Neurons / Q000378:metabolism; D009569:Nitric Oxide / Q000502:physiology; D010084:Oxidation-Reduction; D018384:Oxidative Stress; D011993:Recombinant Fusion Proteins / Q000502:physiology; D012107:Research Design; D013045:Species Specificity; D013356:Subfornical Organ / Q000502:physiology*; D013482:Superoxide Dismutase / Q000235:genetics / Q000502:physiology; D013481:Superoxides / Q000378:metabolism*
D011993:Recombinant Fusion Proteins; D013481:Superoxides; D000804:Angiotensin II; D009569:Nitric Oxide; D013482:Superoxide Dismutase